Redhill BioPharma

RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases.

RedHill’s U.S. commercial operations, headquartered in Raleigh, NC, include a gastrointestinal-focused sales force promoting specialty gastrointestinal drugs in the U.S.

RedHill’s pipeline includes several drug candidates in advanced stages of clinical development, addressing clear medical needs and aiming to relieve suffering.